1. All
  2. Press Releases
  3. Events
  4. Publications

Primo Biotech’s Innovative Radiopharmaceutical Enrolls First Patient, Marking a New Milestone in Precision Medicine for Colorectal Cancer

Press Releases

Radium-223’s Impact on Skeletal Events in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis

Publications

Cost-Utility Analysis of 18F-FDG Imaging: A Network Meta-Analysis of Diagnostic Modalities

Publications

Advancing Early Detection: PSMA PET and Biomarkers Redefine Prostate Cancer Diagnosis

Press Releases

Sincerely Inviting You to A New Era in Prostate Cancer Diagnosis — Nuclear Medicine Driving Clinical Breakthroughs

Events

Primo Goes Global: Radioligand Theranostics Take the Stage at AACR on Campus

Events

Primo Shines at the 2025 Annual Conference of TSNM, showcasing Breakthrough Innovations

Events

Primo Biotechnology and Anbogen Therapeutics Forge Strategic Collaboration to Co-Develop Precision Radioligand for Solid Tumors Diagnosis and Therapy

Press Releases

Primo Biotechnology and Terthera B.V. Announce Strategic Partnership to Advance Terbium-161 Radioligand Therapies in Taiwan

Press Releases
普瑞默生技完成A輪募資 目標2026啟動IPO布局全球放射藥物市場

Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy

Press Releases

Primo’s Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.

Press Releases

Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market

Press Releases